SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001279569-23-001351
Filing Date
2023-10-27
Accepted
2023-10-26 20:07:01
Documents
14
Period of Report
2023-10-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 23988
2 PRESS RELEASE DATED OCTOBER 26, 2023 ex991.htm EX-99.1 17138
3 GRAPHIC logo.jpg GRAPHIC 9119
  Complete submission text file 0001279569-23-001351.txt   234281

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA epix-20231026.xsd EX-101.SCH 3021
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE epix-20231026_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epix-20231026_pre.xml EX-101.PRE 22363
8 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3404
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37410 | Film No.: 231351728
SIC: 2834 Pharmaceutical Preparations